5,627 Shares in The Allstate Corporation $ALL Acquired by Sumitomo Life Insurance Co.

Sumitomo Life Insurance Co. acquired a new position in shares of The Allstate Corporation (NYSE:ALL) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,627 shares of the insurance provider’s stock, valued at approximately $1,339,000.

Several other large investors also recently added to or reduced their stakes in ALL. Brighton Jones LLC boosted its position in shares of Allstate by 60.2% during the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock valued at $1,253,000 after acquiring an additional 2,443 shares during the last quarter. Revolve Wealth Partners LLC acquired a new stake in Allstate during the fourth quarter worth about $231,000. WINTON GROUP Ltd purchased a new position in Allstate during the second quarter worth about $210,000. Treasurer of the State of North Carolina raised its stake in Allstate by 2.5% during the second quarter. Treasurer of the State of North Carolina now owns 123,272 shares of the insurance provider’s stock worth $24,816,000 after purchasing an additional 3,051 shares during the period. Finally, Ieq Capital LLC boosted its holdings in Allstate by 20.1% in the 2nd quarter. Ieq Capital LLC now owns 38,316 shares of the insurance provider’s stock valued at $7,713,000 after purchasing an additional 6,412 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Allstate

In other Allstate news, insider John E. Dugenske sold 32,996 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $269.33, for a total value of $8,886,812.68. Following the sale, the insider owned 13,054 shares of the company’s stock, valued at $3,515,833.82. This trade represents a 71.65% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Andrea Redmond sold 2,225 shares of Allstate stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the transaction, the director owned 2,225 shares of the company’s stock, valued at $451,474.75. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 91,446 shares of company stock valued at $24,208,675 in the last quarter. Corporate insiders own 1.55% of the company’s stock.

Trending Headlines about Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Price Performance

ALL opened at $253.82 on Friday. The firm has a market cap of $64.18 billion, a price-to-earnings ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The Allstate Corporation has a 12-month low of $188.08 and a 12-month high of $277.22. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The stock’s 50-day moving average price is $250.34 and its 200 day moving average price is $224.95.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating analysts’ consensus estimates of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The firm had revenue of $18.60 billion during the quarter, compared to analysts’ expectations of $15.46 billion. During the same quarter in the previous year, the business posted $5.94 earnings per share. The business’s quarterly revenue was up 11.8% compared to the same quarter last year. As a group, sell-side analysts expect that The Allstate Corporation will post 34.45 earnings per share for the current year.

Allstate Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date is Monday, August 31st. This represents a $4.32 annualized dividend and a yield of 1.7%. Allstate’s dividend payout ratio is 8.63%.

Analyst Ratings Changes

Several analysts have recently weighed in on ALL shares. Wall Street Zen raised shares of Allstate from a “hold” rating to a “buy” rating in a research note on Monday, July 20th. Cantor Fitzgerald lifted their price target on shares of Allstate from $236.00 to $242.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. JPMorgan Chase & Co. upped their price objective on Allstate from $282.00 to $292.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. HSBC lowered Allstate from a “buy” rating to a “hold” rating and increased their price objective for the stock from $244.00 to $264.00 in a research report on Monday, July 6th. Finally, UBS Group raised their target price on Allstate from $261.00 to $275.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Four investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, Allstate presently has an average rating of “Hold” and an average price target of $265.26.

Allstate Company Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.